The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Xie, Tao
PropertyValue
overview Tao Xie, MD, PhD, specializes in the diagnosis and treatment of various movement disorders, including Parkinson's disease, progressive supranuclear palsy (PSP), multiple system atrophy (MSA), cortical basal ganglionic degeneration (CBGD), Huntington's disease (HD) and chorea, tremor, dystonia, hemifacial spasm, blepharospasm, tics, and Tourette syndrome. He uses medications, botulinum toxin injection and deep brain stimulation surgery for treatment of these neurological conditions. In his clinical research, Dr. Xie studies the effectiveness of deep brain stimulation for the treatment of various movement disorders. He is also actively involved in clinical trials and research in Parkinson’s disease, PSP, MSA and tremor, and also the role of the DatScan in movement disorders. Dr. Xie is a physician in the University of Chicago Center for Parkinson's Disease and Movement Disorders. Dedicated as a Center for Advanced Research by the American Parkinson Disease Association, this multidisciplinary center combines clinical expertise with state-of-the-art therapies and groundbreaking research.
One or more keywords matched the following items that are connected to Xie, Tao
Item TypeName
Concept Supranuclear Palsy, Progressive
Academic Article Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial.
Academic Article Progression of brain atrophy in PSP and CBS over 6 months and 1 year.
Academic Article CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP.
Academic Article Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial.
Academic Article Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.
Academic Article Disease course and treatment patterns in progressive supranuclear palsy: A real-world study.
Academic Article Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care.
Academic Article Severity of Downgaze Palsy in the Context of Disease Duration Could Estimate Survival Duration in Patients With Progressive Supranuclear Palsy.
Academic Article Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study.
Academic Article A Modified Progressive Supranuclear Palsy Rating Scale for Virtual Assessments.
Academic Article Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.
Academic Article Using Downgaze Palsy Progression Rate to Model Survival in Progressive Supranuclear Palsy-Richardson Syndrome.
Academic Article Early, Middle, and Late-Stage Progression Rates in Progressive Supranuclear palsy-Richardson Syndrome.
Search Criteria
  • Paralysis